Dysregulation of sex hormone metabolism plays a critical role in PE placental dysplasia by affecting trophoblast differentiation and uterine-placenta angiogenesis (Morales et al., 1995; Maliqueo et al., 2016; Berkane et al., 2017; Berkane et al., 2018). Here, PLXNA3 is linked to dysplasia.